The Center for Clinical and Translational Science will hold its 17th Annual Spring Conference on April 5, 2022, focusing on “Climate and Health.” This year’s keynote speaker is Robert Bullard, Ph.D., Distinguished Professor of Urban Planning and Environmental Policy at Texas Southern University. 

Researchers at the University of Arkansas for Medical Sciences (UAMS), the University of Kansas Medical Center (KUMC), and the University of Kentucky (UK) are teaming up to develop a new Clinical and Translational Science Award (CTSA) research network to support translational science across a criminal justice continuum that impacts millions of lives.

A new program supported by the UK’s Center for Research on Violence Against Women (CRVAW) and Center for Clinical and Translational Science (CCTS) will provide seed funding for research projects that address violence against women.

"UK at the Half" airs during halftime of each UK football and basketball game broadcast and features the people, programs, research, health care and service that combine to make UK the university for Kentucky.

A team at the UK Center for Clinical and Translational Science (CCTS) chose a novel approach to target e-cigarette use by young adults — a research-based comic book.

The University of Kentucky Center for Clinical and Translational Science (CCTS) has received a $23.5 million, four-year award from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health.

The University of Kentucky has been selected as a site for a trial to assess dose levels of a Johnson & Johnson booster shot.

During Alex Flannery's tenure in critical care, the University of Kentucky College of Pharmacy assistant professor and 2011 graduate, saw many cases of sepsis and acute kidney injury, which have no cure. Flannery’s background in pharmacology sparked an interest in learning more about how to treat these diseases.

Research led by Dr. Philip Kern was recently highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases.

This study will help definitively answer whether the FDA-authorized Moderna COVID-19 vaccine prevents the spread of the virus, and not just illness in the person who is vaccinated.